Orange Book product · Generic (ANDA)
SAXAGLIPTIN
SAXAGLIPTIN HYDROCHLORIDE
Generic (ANDA)ANDA 205994TE ABRX GLENMARK PHARMS LTD
At a glance
Jul 31, 2023
Approved
Generic (ANDA)
Application
AB
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Jul 31, 2023
2 yr 11 mo ago
Today
Pharmaceutical detail
Active ingredient
SAXAGLIPTIN HYDROCHLORIDE
Strength
EQ 2.5MG BASE
Dosage form
TABLET
Route
ORAL
TE code
AB
Application
ANDA 205994
Product number
001
Marketing status
RX
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of SAXAGLIPTIN HYDROCHLORIDE
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
